Careers  |  Sign In  |  Register
Course List
  • CME Information

Provider Statement

This continuing medical education activity is provided by Vindico Medical Education.

Support Statement

This activity is supported by an educational grant from Lilly.


Alzheimer’s disease is a devastating and progressive illness without any known prevention, cure, or method to reverse this disease. Alzheimer's disease is the sixth leading cause of death in the United States. Only 45% of patients with Alzheimer’s disease or their caregivers will actually be told of their diagnosis. Earlier diagnosis will enable initiation of interventions that may slow the disease course. Biomarkers and several imaging modalities are now available to help achieve a definitive diagnosis. In this CME activity, leading clinicians will discuss the latest evidence-based strategies for the early diagnosis of Alzheimer’s disease, management strategies for pre-symptomatic and mild Alzheimer’s disease, and the latest safety and efficacy data for new and emerging agents for treating Alzheimer’s disease.

Target Audience

The intended audience for the activity is primary care providers, neurologists, gerontologists, radiologists, nuclear medicine physicians, and other health care professionals involved in the treatment of patients with Alzheimer’s disease.

Learning Objectives

Upon successful completion of the video series, participants should be better able to:

  • Evaluate evidence-based strategies for the early diagnosis of Alzheimer’s disease.
  • Review the latest data of the pathophysiology and management strategies for pre-symptomatic and mild Alzheimer’s disease.
  • Evaluate the latest safety and efficacy data for new and emerging agents for the treatment of Alzheimer’s disease.


Ranjan Duara, MD, FAAN
Medical Director
Wien Center for Alzheimer’s Disease and Memory Disorders
Mount Sinai Medical Center
Miami Beach, FL


Consulting Fees: Piramal
Speakers Bureau: Eli Lilly, Medical Learning Group
Contracted Research: Avid Radiopharmaceuticals, Eli Lilly, Merck, Navidea Biopharmaceuticals, Toyama Chemical, vTv Therapeutics

Marc E. Agronin, MD
Vice President, Behavioral Health and Clinical Research
Miami Jewish Health Systems
Miami, FL


Consulting Fee: Eli Lilly
Speakers Bureau: Allergan


Julie A. Schneider, MD, MS
No relevant financial relationships to disclose.

Ronald A. Codario MD, FACP, FNLA, RPVI, CHCP
No relevant financial relationships to disclose.

Vindico Medical Education staff report the following relationship(s)

No relevant financial relationships to disclose.

Signed disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.


In accordance with the Accreditation Council for Continuing Education's Standards for Commercial Support, all planners, teachers, authors, and reviewers involved in the development of CME content are required to disclose to the accredited provider their relevant financial relationships. Relevant financial relationships will be disclosed to the activity audience prior to viewing content.


Vindico Medical Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation

Vindico Medical Education designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credit(s)™, 0.25 credits per video. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This enduring material is approved for 1 year from the date of original release, October 11th, 2016 to October 10th, 2017.

How to Participate in this Activity and Obtain CME Credit

To participate in this CME activity, you must read the objectives, answer the pretest questions, view the videos, complete the CME posttest, and complete and return the registration form and evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 66% of the posttest questions correctly for each video. Upon receipt of the completed materials, if a satisfactory score on the posttest is achieved, Vindico Medical Education will issue an AMA PRA Category 1 Credit(s)™ certificate.

Unlabeled and Investigational Usage

The audience is advised that this continuing medical education activity may contain references to unlabeled uses of FDA-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non-FDA approved or investigational use of products/devices.

Copyright Statement

Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright © 2016 Vindico Medical Education. All rights reserved.

No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any of Vindico Medical Education continuing education activities does not necessarily reflect the views and opinions of Vindico Medical Education. Neither Vindico Medical Education nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the US Food and Drug Administration. All readers and continuing education participants should verify all information before treating patients or utilizing any product.

Educational Tools

For downloadable handouts, patient education tools, and online resources for your clinical practice provided by Vindico Medical Education, please visit:

Alzheimer’s Disease Fact Sheet

CME Questions?

Contact us at or 856-994-9400, ext. 504.